These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4368352)

  • 1. A semi-automated in vitro assay for CRF: activities of peptides related to oxytocin and vasopressin.
    Pearlmutter AF; Rapino E; Saffran M
    Neuroendocrinology; 1974; 15(2):106-19. PubMed ID: 4368352
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolated pituitary cells: CRF-like activity of neurohypophysial and related polypeptides.
    Portanova R; Sayers G
    Proc Soc Exp Biol Med; 1973 Jul; 143(3):661-6. PubMed ID: 4352530
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of vasopressin and of a crude CRF preparation on pituitary ACTH-release in posterior-lobectomized rats.
    de Wied D
    Neuroendocrinology; 1968; 3(3):129-35. PubMed ID: 4301554
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of assays for corticotrophin-releasing activity.
    Chan LT; de Wied D; Saffran M
    Endocrinology; 1969 Apr; 84(4):967-72. PubMed ID: 4304035
    [No Abstract]   [Full Text] [Related]  

  • 5. Dissociation of the adrenocorticotropin secretory responses to corticotropin-releasing factor (CRF) and vasopressin or oxytocin by using a specific cytotoxic analog of CRF.
    Schwartz J; Vale W
    Endocrinology; 1988 Apr; 122(4):1695-700. PubMed ID: 2831039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of corticotropin release by corticotropin-releasing factor (CRF) or by vasopressin following intrapituitary infusions in unanesthetized dogs: inhibition of the responses by dexamethasone.
    Gonzalez-Luque A; L'age M; Dhariwal AP; Yates FE
    Endocrinology; 1970 May; 86(5):1134-42. PubMed ID: 4314067
    [No Abstract]   [Full Text] [Related]  

  • 7. Potentiation by vasopressin of corticotropin release induced by corticotropin-releasing factor.
    Yates FE; Russell SM; Dallman MF; Hodge GA; McCann SM; Dhariwal AP
    Endocrinology; 1971 Jan; 88(1):3-15. PubMed ID: 4320769
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin II and ACTH release: site of action and potency relative to corticotropin releasing factor and vasopressin.
    Spinedi E; Negro-Vilar A
    Neuroendocrinology; 1983 Dec; 37(6):446-53. PubMed ID: 6318148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ACTH releasing action of vasopressin].
    Hiroshige T
    Saishin Igaku; 1971 Apr; 26(4):697-705. PubMed ID: 4329833
    [No Abstract]   [Full Text] [Related]  

  • 10. Release of corticotropin and corticotropin-releasing factors from rat posterior pituitary in vitro.
    Bény JL; Baertschi AJ
    Neuroendocrinology; 1980; 30(2):108-12. PubMed ID: 6243758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of ACTH by substances of central nervous system origin.
    de Wied D; Witter A; Versteeg DH; Mulder AH
    Endocrinology; 1969 Sep; 85(3):561-9. PubMed ID: 4307362
    [No Abstract]   [Full Text] [Related]  

  • 12. An in vitro assay for corticotropin releasing factor(s) using suspensions of isolated pituitary cells.
    Portanova R; Sayers G
    Neuroendocrinology; 1973; 12(4):236-48. PubMed ID: 4354350
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo potentiation of corticotropin releasing factor activity by vasopressin analogues.
    Fischman AJ; Moldow RL
    Life Sci; 1984 Sep; 35(12):1311-9. PubMed ID: 6332965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the corticotrophin-releasing activity of vasopressin, using ACTH secretion by cultured rat adenohypophyseal cells.
    Yasuda N; Greer MA
    Endocrinology; 1976 Apr; 98(4):936-42. PubMed ID: 179790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of oxytocin on corticotrope function in humans: are vasopressin and oxytocin ying-yang neurohormones?
    Legros JJ
    Psychoneuroendocrinology; 2001 Oct; 26(7):649-55. PubMed ID: 11500247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of corticotropin-releasing factor, neurohypophyseal peptides, and catecholamines on pituitary function.
    Rivier C; Vale W
    Fed Proc; 1985 Jan; 44(1 Pt 2):189-95. PubMed ID: 2981740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic peptide regulation of ACTH secretion from sheep pituitary.
    Kemppainen RJ; Clark TP; Sartin JL; Zerbe CA
    Am J Physiol; 1993 Oct; 265(4 Pt 2):R840-5. PubMed ID: 8238455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of adrenocorticotropin/beta-endorphin release by synthetic ovine corticotropin-releasing factor in vitro. Enhancement by various vasopressin analogs.
    Knepel W; Homolka L; Vlaskovska M; Nutto D
    Neuroendocrinology; 1984 May; 38(5):344-50. PubMed ID: 6328345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the presence of tumor peptides with corticotropin-releasing-factor-like activity in the ectopic ACTH syndrome.
    Upton GV; Amatruda TT
    N Engl J Med; 1971 Aug; 285(8):419-24. PubMed ID: 4326719
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of histamine, hog vasopressin, and corticotropin-releasing factor (CRF) on ACTH release in vitro.
    SAFFRAN M; SCHALLY AV
    Proc Soc Exp Biol Med; 1956 Jul; 92(3):636-7. PubMed ID: 13359490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.